BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28378140)

  • 1. Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.
    Thacker N; Bakhshi S; Chinnaswamy G; Vora T; Prasad M; Bansal D; Agarwala S; Kapoor G; Radhakrishnan V; Laskar S; Kaur T; Rath GK; Dhaliwal RS; Arora B
    Indian J Pediatr; 2017 May; 84(5):382-392. PubMed ID: 28378140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
    Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.
    Reiter A; Schrappe M; Parwaresch R; Henze G; Müller-Weihrich S; Sauter S; Sykora KW; Ludwig WD; Gadner H; Riehm H
    J Clin Oncol; 1995 Feb; 13(2):359-72. PubMed ID: 7844597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
    Seidemann K; Tiemann M; Schrappe M; Yakisan E; Simonitsch I; Janka-Schaub G; Dörffel W; Zimmermann M; Mann G; Gadner H; Parwaresch R; Riehm H; Reiter A
    Blood; 2001 Jun; 97(12):3699-706. PubMed ID: 11389005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
    Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
    Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of pediatric non-Hodgkin lymphoma in Central America: A report of the Association of Pediatric Hematology Oncology of Central America (AHOPCA).
    Peña-Hernandez A; Ortiz R; Garrido C; Gomez-Garcia W; Fuentes-Alabi S; Martinez R; Metzger ML; Chantada GL; Ribeiro RC
    Pediatr Blood Cancer; 2019 May; 66(5):e27621. PubMed ID: 30677231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric non-Hodgkin lymphoma: a retrospective 14-year experience with Berlin-Frankfurt-Münster (BFM) protocols from a tertiary care hospital in Serbia.
    Dokmanovic L; Krstovski N; Vukanic D; Brasanac D; Rodic P; Cvetkovic M; Janic D
    Pediatr Hematol Oncol; 2012 Mar; 29(2):109-18. PubMed ID: 22376014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.
    Burkhardt B; Zimmermann M; Oschlies I; Niggli F; Mann G; Parwaresch R; Riehm H; Schrappe M; Reiter A;
    Br J Haematol; 2005 Oct; 131(1):39-49. PubMed ID: 16173961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
    Seidemann K; Tiemann M; Lauterbach I; Mann G; Simonitsch I; Stankewitz K; Schrappe M; Zimmermann M; Niemeyer C; Parwaresch R; Riehm H; Reiter A;
    J Clin Oncol; 2003 May; 21(9):1782-9. PubMed ID: 12721255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
    J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics and treatment outcome of 36 cases with non-Hodgkin's lymphoma arising from mediastinum in children].
    Tang YJ; Tang JY; Pan C; Xue HL; Chen J; Shen SH; Dong L; Zhou M; Wang YP; Gu LJ; Jiang H; Ye QD
    Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):687-90. PubMed ID: 20021793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of children and adolescents with non-Hodgkin's lymphoma (results based on the NHL Berlin-Frankfurt-Münster 90 protocols).
    Kavan P; Kabicková E; Gajdos P; Koutecký J; Smelhaus V; Stanková J; McClain KL
    Cas Lek Cesk; 1999 Jan; 138(2):40-6. PubMed ID: 10376402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised International Pediatric Non-Hodgkin Lymphoma Staging System.
    Rosolen A; Perkins SL; Pinkerton CR; Guillerman RP; Sandlund JT; Patte C; Reiter A; Cairo MS
    J Clin Oncol; 2015 Jun; 33(18):2112-8. PubMed ID: 25940716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single center.
    Karadeniz C; Oguz A; Citak EC; Uluoglu O; Okur V; Demirci S; Okur A; Aksakal N
    Pediatr Hematol Oncol; 2007 Sep; 24(6):417-30. PubMed ID: 17710659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results of modified BFM protocol in pediatric high-risk Burkitt lymphoma.
    Vural S; Genç DB; Kebudi R; Doğan Ö; Karaman S
    Turk J Pediatr; 2021; 63(4):639-647. PubMed ID: 34449146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL].
    Reiter A; Schrappe M; Yakisan E; Sauter S; Ebell W; Zimmermann M; Hartmann W; Kremens B; Kuhn N; Claviez A
    Klin Padiatr; 1994; 206(4):242-52. PubMed ID: 7967420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Hodgkin lymphoma in children and adolescents.
    Reiter A
    Klin Padiatr; 2013 May; 225 Suppl 1():S87-93. PubMed ID: 23700066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report.
    Cairo MS; Krailo MD; Morse M; Hutchinson RJ; Harris RE; Kjeldsberg CR; Kadin ME; Radel E; Steinherz LJ; Morris E; Finlay JL; Meadows AT
    Leukemia; 2002 Apr; 16(4):594-600. PubMed ID: 11960338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.